Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway
- Status
- COMPLETED
- Phase
- PHASE2
Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE1
Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC
- Status
- COMPLETED
- Phase
- PHASE2
Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)
- Status
- COMPLETED
- Phase
- PHASE3
Avelumab in First-line NSCLC (JAVELIN Lung 100)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1